SYRA Syra Health Corp
Services-Employment Agencies · OTC · SEC CIK 1922335 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY19.5%
TTM net income YoY155.4%
TTM EPS YoY150.0%
Revenue 3-yr CAGR16.2%
Net income 3-yr CAGR—
Margins
Gross margin42.6%
Operating margin6.8%
Net margin7.8%
FCF margin—
EBITDA margin6.8%
Returns
ROE26.8%
ROA18.7%
ROIC (approx.)109.8%
Asset turnover2.39x
Leverage & solvency
Liabilities / assets28.4%
Debt / equity0.00x
Current ratio3.47x
Interest coverage58.86x
Cash quality & payout
Operating cash flow / net income0.98x
Accruals ratio0.4%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $2.56M | $2.39M | $2.27M | $1.73M | $1.69M | $1.95M | $1.86M | $2.01M |
| Cost of revenue | $1.37M | $1.33M | $1.30M | $1.14M | $1.13M | $1.19M | $1.27M | $1.55M |
| Gross profit | $1.19M | $1.07M | $971,255 | $591,170 | $554,541 | $752,895 | $589,156 | $455,371 |
| R&D expense | $46,716 | $47,351 | $6,921 | $139 | $816 | $29,712 | $37,173 | -$5,117 |
| SG&A expense | $222,141 | $236,485 | $213,047 | $236,635 | $252,384 | $289,070 | $287,287 | $298,028 |
| Operating income | $300,002 | $251,571 | $190,983 | -$135,661 | -$232,171 | -$63,158 | -$473,334 | -$501,668 |
| Interest expense | $1,353 | $2,217 | $2,462 | $4,278 | $1,905 | $3,858 | $3,229 | $5,528 |
| Pretax income | $299,657 | — | — | — | -$225,902 | — | — | — |
| Income tax | -$44,953 | — | — | — | — | — | — | — |
| Net income | $344,610 | $250,242 | $240,979 | -$134,570 | -$225,902 | -$63,596 | -$472,265 | -$504,397 |
| EBITDA | $300,717 | $252,312 | $192,037 | -$133,364 | -$226,775 | -$57,180 | -$466,537 | -$494,390 |
| EPS (basic) | 0.02 | 0.02 | 0.02 | — | -0.02 | -0.01 | -0.04 | — |
| EPS (diluted) | 0.02 | 0.02 | 0.02 | — | -0.02 | -0.01 | -0.04 | — |
| Weighted avg. shares (diluted) | 15.14M | 13.55M | 12.78M | — | 11.94M | 11.94M | 11.59M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $2.38M | $2.12M | $2.92M | $1.61M | $1.98M | $2.31M | $2.49M | $2.40M |
| Receivables | $1.52M | $1.47M | $869,132 | $918,374 | $926,255 | $886,361 | — | $680,827 |
| Current assets | $4.16M | $3.75M | $3.93M | $2.74M | $3.21M | $3.43M | $3.65M | $3.35M |
| PP&E, net | $4,476 | $5,192 | $5,932 | $6,986 | $9,176 | $14,572 | $20,550 | $27,347 |
| Total assets | $4.23M | $3.83M | $3.94M | $2.77M | $3.26M | $3.47M | $3.72M | $3.68M |
| Current liabilities | $1.20M | $1.20M | $1.58M | $674,739 | $1.05M | $1.06M | $1.27M | $613,549 |
| Total liabilities | $1.20M | $1.20M | $1.58M | $674,739 | $1.05M | $1.06M | $1.27M | $800,761 |
| Shareholders' equity | $3.02M | $2.63M | $2.36M | $2.10M | $2.21M | $2.41M | $2.46M | $2.88M |
| Cash flow statement | ||||||||
| Operating cash flow | $331,840 | -$718,762 | $1.36M | -$289,192 | -$244,308 | -$72,477 | $158,231 | -$214,720 |
| Capital expenditure | — | — | — | — | — | — | — | $0 |
| Free cash flow | — | — | — | — | — | — | — | -$214,720 |
| Investing cash flow | — | — | — | — | — | — | — | $0 |
| Financing cash flow | -$72,174 | -$79,809 | -$54,360 | -$72,513 | -$85,071 | -$112,184 | -$63,051 | -$87,334 |
| Depreciation & amortization | $715 | $741 | $1,054 | $2,297 | $5,396 | $5,978 | $6,797 | $7,278 |
| Stock-based compensation | $45,246 | $21,095 | $23,344 | $23,360 | $21,127 | $21,123 | $32,944 | $31,317 |
Free plan shows the latest 8 periods; Pro shows all 17 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.